Changes in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer

被引:21
作者
Linares-Galiana, Isabel [1 ,2 ]
Berenguer-Frances, Miguel Angel [1 ,2 ]
Canas-Cortes, Rut [2 ]
Pujol-Canadell, Monica [2 ]
Comas-Anton, Silvia [3 ]
Martinez, Evelyn [1 ]
Laplana, Maria [1 ]
Perez-Montero, Hector [1 ]
Pla-Farnos, Maria Jesus [4 ]
Navarro-Martin, Arturo [1 ,2 ]
Nunez, Miriam [1 ,2 ]
Both, Brigitte [5 ]
Guedea, Ferran [1 ,2 ]
机构
[1] Hosp Duran & Reynals, Inst Catala Oncol ICO, Radiat Oncol Dept, Avinguda Gran Via Hosp 199-203, Barcelona 08098, Spain
[2] Inst Invest Biomed Bellvitge IDIBELL, ONCOBELL Program, Radiobiol & Canc Grp, Avinguda Gran Via Hosp 199-203, Barcelona 08098, Spain
[3] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol ICO, Radiat Oncol Dept, Carretera Canyet S-N, Badalona 08916, Spain
[4] Hosp Univ Bellvitge, Gynecol Dept, Carrer Feixa Llarga S-N, Barcelona 08907, Spain
[5] Carl Zeiss Meditec AG, ZEISS Grp, Business Sect Radiotherapy, Med Technol Business Grp,Med Affairs & Proff Educ, Rudolf Eber Str 11, Oberkochen, Germany
关键词
immune system; immunomodulation; flow cytometry; immunophenotyping; breast cancer; intraoperative radiation therapy; NK CELLS; RADIOTHERAPY; IRRADIATION;
D O I
10.1093/jrr/rraa083
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A detailed understanding of the interactions and the best dose-fractionation scheme of radiation to maximize antitumor immunity have not been fully established. In this study, the effect on the host immune system of a single dose of 20 Gy through intraoperative radiation therapy (IORT) on the surgical bed in low-risk breast cancer patients undergoing conserving breast cancer has been assessed. Peripheral blood samples from 13 patients were collected preoperatively and at 48 h and 3 and 10 weeks after the administration of radiation. We performed a flow cytometry analysis for lymphocyte subpopulations, natural killer cells (NK), regulatory T cells (Treg) and myeloid-derived suppressor cells (MDSCs). We observed that the subpopulation of NK CD56(+high) CD16(+) increased significantly at 3 weeks after IORT (0.30-0.42%, P < 0.001), while no changes were found in immunosuppressive profile, CD4(+) CD25(+) Foxp3(+)Helios(+) Treg cells, granulocyticMDSCs (G-MDSCs) andmonocyticMDSCs (Mo-MDSCs). A single dose of IORT may be an effective approach to improve antitumor immunity based on the increase in NK cells and the non-stimulation of immunosuppressive cells involved in immune escape. These findings support future combinations of IORT with immunotherapy, if they are confirmed in a large cohort of breast cancer patients.
引用
收藏
页码:110 / 118
页数:9
相关论文
共 42 条
[1]   Natural and induced T regulatory cells in cancer [J].
Adeegbe, Dennis O. ;
Nishikawa, Hiroyoshi .
FRONTIERS IN IMMUNOLOGY, 2013, 4
[2]   Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer [J].
Andre, Fabrice ;
Dieci, Maria V. ;
Dubsky, Peter ;
Sotiriou, Christos ;
Curigliano, Giuseppe ;
Denkert, Carsten ;
Loi, Sherene .
CLINICAL CANCER RESEARCH, 2013, 19 (01) :28-33
[3]   The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence [J].
Barker, Holly E. ;
Paget, James T. E. ;
Khan, Aadil A. ;
Harrington, Kevin J. .
NATURE REVIEWS CANCER, 2015, 15 (07) :409-425
[4]   Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding [J].
Belletti, Barbara ;
Vaidya, Jayant S. ;
D'Andrea, Sara ;
Entschladen, Frank ;
Roncadin, Mario ;
Lovat, Francesca ;
Berton, Stefania ;
Perin, Tiziana ;
Candiani, Ezio ;
Reccanello, Sonia ;
Veronesi, Andrea ;
Canzonieri, Vincenzo ;
Trovo, Mauro G. ;
Zaenker, Kurt S. ;
Colombatti, Alfonso ;
Baldassarre, Gustavo ;
Massarut, Samuele .
CLINICAL CANCER RESEARCH, 2008, 14 (05) :1325-1332
[5]   Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy [J].
Bos, Paula D. ;
Plitas, George ;
Rudra, Dipayan ;
Lee, Sue Y. ;
Rudensky, Alexander Y. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (11) :2435-2446
[6]   Radiation for awakening the dormant immune system, a promising challenge to be explored [J].
de la Cruz-Merino, Luis ;
Illescas-Vacas, Ana ;
Grueso-Lopez, Ana ;
Barco-Sanchez, Antonio ;
Miguez-Sanchez, Carlos .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[7]   Role of Local Radiation Therapy in Cancer Immunotherapy [J].
Demaria, Sandra ;
Golden, Encouse B. ;
Formenti, Silvia C. .
JAMA ONCOLOGY, 2015, 1 (09) :1325-1332
[8]   Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials [J].
Early Breast Cancer Trialists' Collaborative Group .
LANCET, 2000, 355 (9217) :1757-1770
[9]   Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway [J].
Fabris, L. ;
Berton, S. ;
Citron, F. ;
D'Andrea, S. ;
Segatto, I. ;
Nicoloso, M. S. ;
Massarut, S. ;
Armenia, J. ;
Zafarana, G. ;
Rossi, S. ;
Ivan, C. ;
Perin, T. ;
Vaidya, J. S. ;
Avanzo, M. ;
Roncadin, M. ;
Schiappacassi, M. ;
Bristow, R. G. ;
Calin, G. ;
Baldassarre, G. ;
Belletti, B. .
ONCOGENE, 2016, 35 (37) :4914-4926
[10]   The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology [J].
Finkelstein, Steven Eric ;
Timmerman, Robert ;
McBride, WilliamH. ;
Schaue, Doerthe ;
Hoffe, Sarah E. ;
Mantz, Constantine A. ;
Wilson, George D. .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011,